Cue Biopharma, Inc. (CUE)
0.4932
+0.02
(+3.33%)
USD |
NASDAQ |
Dec 11, 16:00
0.49
0.00 (0.00%)
After-Hours: 20:00
Cue Biopharma Free Cash Flow: -29.82M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Insmed, Inc. | -906.14M |
| Puma Biotechnology, Inc. | 42.87M |
| Mersana Therapeutics, Inc. | -74.37M |
| Adaptive Biotechnologies Corp. | -62.94M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.024M |
| Cash from Investing (Quarterly) | -6.768M |
| Cash from Financing (Quarterly) | 0.001M |
| Free Cash Flow Per Share (Quarterly) | -0.0895 |
| Free Cash Flow to Equity (Quarterly) | -7.563M |
| Free Cash Flow to Firm (Quarterly) | -8.949M |
| Free Cash Flow Yield | -70.13% |